These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3438618)

  • 21. General statistical design considerations of randomized clinical trials.
    Peduzzi P
    Prog Clin Biol Res; 1988; 264():61-70. PubMed ID: 3289035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interim futility analysis with intermediate endpoints.
    Goldman B; LeBlanc M; Crowley J
    Clin Trials; 2008; 5(1):14-22. PubMed ID: 18283075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Lopressor Intervention Trial: multicentre study of metoprolol in survivors of acute myocardial infarction. Lopressor Intervention Trial Research Group.
    Eur Heart J; 1987 Oct; 8(10):1056-64. PubMed ID: 2890522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early stopping in the two-sample problem for bounded random variables.
    DeMets DL; Halperin M
    Control Clin Trials; 1982 Mar; 3(1):1-11. PubMed ID: 7067469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metoprolol in acute myocardial infarction. Patients and methods. The MIAMI Trial Research Group.
    Am J Cardiol; 1985 Nov; 56(14):3G-9G. PubMed ID: 2865889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AIMS. The design and conduct of a multicentre mortality study comparing placebo and anisoylated plasminogen streptokinase activator complex 30 units intravenously for the treatment of acute myocardial infarction of less than 6 hours duration. UK APSAC Advisory Committee.
    Drugs; 1987; 33 Suppl 3():227-8. PubMed ID: 3315598
    [No Abstract]   [Full Text] [Related]  

  • 28. Sequential stopping rules and sequentially adjusted P values: does one require the other?
    Dupont WD
    Control Clin Trials; 1983 Mar; 4(1):3-10. PubMed ID: 6851579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Once again: controlled clinical trials].
    Berndt H
    Z Arztl Fortbild (Jena); 1983; 77(11):461-3. PubMed ID: 6603718
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term anticoagulant therapy after acute myocardial infarction.
    Goldberg RJ; Gore JM; Dalen JE; Alpert JS
    Am Heart J; 1985 Mar; 109(3 Pt 1):616-22. PubMed ID: 3919548
    [No Abstract]   [Full Text] [Related]  

  • 31. Anticoagulants after myocardial infarction in the elderly.
    Oliver MF
    Lancet; 1981 Jan; 1(8211):101-2. PubMed ID: 6109105
    [No Abstract]   [Full Text] [Related]  

  • 32. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double blind trial of long-term anticoagulant treatment after myocardial infarction.
    Meuwissen OJ; Vervoorn AC; Cohen O; Jordan FL; Nelemans FA
    Acta Med Scand; 1969 Nov; 186(5):361-8. PubMed ID: 4985108
    [No Abstract]   [Full Text] [Related]  

  • 34. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
    Chen YH; Li C; Lan KK
    Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled trial of sotalol for 1 year after myocardial infarction.
    Julian DG; Jackson FS; Szekely P; Prescott RJ
    Circulation; 1983 Jun; 67(6 Pt 2):I61-2. PubMed ID: 6342842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Study design, patient characteristics and conduct of the study.
    Jürgensen HJ; Andersen MP; Bechsgaard P; Frederiksen J; Hansen DA; Nielsen PB; Pedersen F; Pedersen-Bjergaard O; Rasmussen SL
    Acta Med Scand Suppl; 1984; 680():8-17. PubMed ID: 6375283
    [No Abstract]   [Full Text] [Related]  

  • 37. Interim analyses and early termination of clinical trials.
    Choi SC
    J Biopharm Stat; 1997 Nov; 7(4):533-43. PubMed ID: 9358327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction.
    Herlitz J; Elmfeldt D; Hjalmarson A; Holmberg S; Málek I; Nyberg G; Rydén L; Swedberg K; Vedin A; Waagstein F; Waldenström A; Waldenström J; Wedel H; Wilhelmsen L; Wilhelmsson C
    Am J Cardiol; 1983 May; 51(8):1282-8. PubMed ID: 6342352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pathology of the heart following long-term anticoagulant therapy in elderly patients after myocardial infarction. The Dutch sixty-plus reinfarction study.
    de Vries WA; Becker AE
    Int J Cardiol; 1984 Apr; 5(4):507-16. PubMed ID: 6427122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential or fixed sample trial design? A case study by stochastic simulation.
    Skovlund E; Walløe L
    J Clin Epidemiol; 1991; 44(3):265-72. PubMed ID: 1999686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.